Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Systematic review and economic...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.

Show other versions (1)
Bibliographic Details
Main Authors: Clark, W, Raftery, J, Song, F, Barton, P, Cummins, C, Fry-Smith, A, Burls, A
Format: Journal article
Language:English
Published: 2003
  • Holdings
  • Description
  • Other Versions (1)
  • Similar Items
  • Staff View

Similar Items

  • Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
    by: Clark, W, et al.
    Published: (2003)
  • Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease
    by: W. Clark, et al.
    Published: (2003-01-01)
  • Systemic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease
    by: Clark, W, et al.
    Published: (2003)
  • A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
    by: Chen, Y, et al.
    Published: (2006)
  • A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    by: Chen, Y, et al.
    Published: (2006)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs